These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 22546295)

  • 1. Decoupling the role of image size and calorie intake on gastric retention of swelling-based gastric retentive formulations: pre-screening in the dog model.
    Lalloo AK; McConnell EL; Jin L; Elkes R; Seiler C; Wu Y
    Int J Pharm; 2012 Jul; 431(1-2):90-100. PubMed ID: 22546295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and in vitro and in vivo characterization of mucoadhesive matrix pellets of metformin hydrochloride for oral controlled release: a technical note.
    Ige PP; Gattani SG
    Arch Pharm Res; 2012 Mar; 35(3):487-98. PubMed ID: 22477196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suitability of a minipig model in assessing clinical bioperformance of matrix and multiparticulate extended-release formulations for a BCS class III Drug development candidate.
    Kesisoglou F; Xie IH; Manser K; Wu Y; Hardy I; Fitzpatrick S
    J Pharm Sci; 2014 Feb; 103(2):636-42. PubMed ID: 24382706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrated system for dissolution studies and magnetic resonance imaging of controlled release, polymer-based dosage forms-a tool for quantitative assessment of hydrogel formation processes.
    Kulinowski P; Dorozyński P; Jachowicz R; Weglarz WP
    J Pharm Biomed Anal; 2008 Nov; 48(3):685-93. PubMed ID: 18715732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and development of gastroretentive drug delivery system for ofloxacin.
    Ali J; Hasan S; Ali M
    Methods Find Exp Clin Pharmacol; 2006 Sep; 28(7):433-9. PubMed ID: 17003848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: development, optimization and in vitro-in vivo evaluation in healthy human volunteers.
    Tadros MI
    Eur J Pharm Biopharm; 2010 Feb; 74(2):332-9. PubMed ID: 19932750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced formulation design of venlafaxine hydrochloride coated and triple-layer tablets containing hypromellose.
    Gohel M; Bariya SH
    Pharm Dev Technol; 2009; 14(6):650-8. PubMed ID: 19883254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Characterisation of Gastroretentive Solid Dosage Form Based on Melt Foaming.
    Vasvári G; Haimhoffer Á; Horváth L; Budai I; Trencsényi G; Béresová M; Dobó-Nagy C; Váradi J; Bácskay I; Ujhelyi Z; Fehér P; Sinka D; Vecsernyés M; Fenyvesi F
    AAPS PharmSciTech; 2019 Aug; 20(7):290. PubMed ID: 31428895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel method to radiolabel gastric retentive formulations for gamma scintigraphy assessment.
    Burke MD; Staton JS; Vickers AW; Peters EE; Coffin MD
    Pharm Res; 2007 Apr; 24(4):695-704. PubMed ID: 17372696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A framework to investigate drug release variability arising from hypromellose viscosity specifications in controlled release matrix tablets.
    Mitchell SA; Balwinski KM
    J Pharm Sci; 2008 Jun; 97(6):2277-85. PubMed ID: 17828741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the pentagastrin dog model to explore the food effects on formulations in early drug development.
    Zane P; Guo Z; MacGerorge D; Vicat P; Ollier C
    Eur J Pharm Sci; 2014 Jun; 57():207-13. PubMed ID: 24090732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
    Sankalia JM; Sankalia MG; Mashru RC
    J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of hydroxypropyl methylcellulose matrix systems as swellable gastro-retentive drug delivery systems (GRDDS).
    Matharu AS; Motto MG; Patel MR; Simonelli AP; Dave RH
    J Pharm Sci; 2011 Jan; 100(1):150-63. PubMed ID: 20572054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and evaluation of a dry coated drug delivery system with floating-pulsatile release.
    Zou H; Jiang X; Kong L; Gao S
    J Pharm Sci; 2008 Jan; 97(1):263-73. PubMed ID: 17803198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of novel spray coated soft elastic gelatin capsule sustained release formulations of nifedipine.
    Abd El-Sattar Fahmy S; Christensen JM; Ayres JW
    Drug Dev Ind Pharm; 2009 Aug; 35(8):1009-21. PubMed ID: 19274589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-daily propranolol extended-release tablet dosage form: formulation design and in vitro/in vivo investigation.
    Huang YB; Tsai YH; Yang WC; Chang JS; Wu PC; Takayama K
    Eur J Pharm Biopharm; 2004 Nov; 58(3):607-14. PubMed ID: 15451535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
    Kambayashi A; Blume H; Dressman J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine).
    Javadzadeh Y; Jafari-Navimipour B; Nokhodchi A
    Int J Pharm; 2007 Aug; 341(1-2):26-34. PubMed ID: 17498898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and evaluation of once-daily sustained-release coated tablets of tolterodine-L-tartrate.
    Pradhan R; Kim YI; Chang SW; Kim JO
    Int J Pharm; 2014 Jan; 460(1-2):205-11. PubMed ID: 24184032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human.
    Wu Y; Loper A; Landis E; Hettrick L; Novak L; Lynn K; Chen C; Thompson K; Higgins R; Batra U; Shelukar S; Kwei G; Storey D
    Int J Pharm; 2004 Nov; 285(1-2):135-46. PubMed ID: 15488686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.